OncoTherapy Science News

OncoTherapy Science: Notice regarding the occurrence of non-operating expenses

Nov 8 03:00 ET

OncoTherapy Science: Announcement of the conclusion of a joint research agreement on the development and application of drug discovery platforms utilizing artificial intelligence (AI)

Oct 6 19:30 ET

OncoTherapy Science: Announcements of progress in joint research contracts at our consolidated subsidiaries.

Aug 23 04:00 ET

OncoTherapy Science: Announcement regarding the large-scale exercise, completion of exercise, and monthly exercise status of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Aug 23 04:00 ET

OncoTherapy Science: Announcements of individual stocks: Our consolidated subsidiary has signed a joint research agreement with Showa University and Advanced Genomics APAC Co., Ltd. regarding genetic testing for brain tumors.

Aug 20 23:15 ET

OncoTherapy Science: Announcements of individual stocks regarding the monthly exercise status of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Aug 1 02:00 ET

OncoTherapy Science: Announcements of individual stocks: Publication of paper on the results of phase III clinical trial of S-588410 targeting esophageal cancer patients.

Jul 29 19:30 ET

OncoTherapy Science: Announcements of individual stocks: We have entered into a joint research agreement with WOLVES HAND Co., Ltd., our consolidated subsidiary, regarding early detection of cancer through liquid biopsy in the field of veterinary medicine.

Jul 18 19:30 ET

OncoTherapy Science: Announcements of individual stocks regarding the massive exercise of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Jul 4 04:00 ET

OncoTherapy Science: Announcements of individual stocks regarding the introduction of our consolidated subsidiary's next-generation sequencing (NGS) outsourcing analysis services at the on-site seminar.

Jul 3 19:30 ET

OncoTherapy Science: Announcements of individual stocks regarding the monthly exercise status of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Jul 1 02:00 ET

OncoTherapy Science: Announcements of individual stocks regarding the status of joining the Public Interest Incorporated Foundation Financial Accounting Standards Board and thoughts on joining.

Jun 28 04:00 ET

OncoTherapy Science: Matters related to business plans and growth potential.

Jun 25 04:00 ET

OncoTherapy Science: Research and Development Briefing Materials

Jun 24 19:30 ET

OncoTherapy Science: 23rd Annual General Meeting of Shareholders Presentation Slides (Company Overview)

Jun 24 19:30 ET

OncoTherapy Science: Announcements of individual stocks regarding the massive exercise of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Jun 14 04:00 ET

OncoTherapy Science: Announcements of individual stocks regarding immunotherapy for type 2 neurofibromatosis from Keio University School of Medicine.

Jun 12 19:30 ET

OncoTherapy Science: Independent Company Executives Declaration

Jun 12 04:00 ET

OncoTherapy Science: Announcements of individual stocks regarding the massive exercise of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.

Jun 5 04:00 ET

OncoTherapy Science: Notice regarding the monthly exercise status of the 36th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Jun 3 02:00 ET